2-AG

🧬 This brief summary references 2-arachidonoylglycerol (2-AG), one of the two primary endogenous cannabinoids, which is important for clinicians to understand as cannabis products increasingly interact with the endocannabinoid system in patient populations. The emphasis on quality assurance and molecular characterization reflects the broader scientific effort to standardize cannabinoid research, though it is worth noting that product purity and potency in commercial cannabis remain poorly regulated across most jurisdictions, creating a gap between research-grade and real-world exposures. Clinicians should recognize that 2-AG, like anandamide, plays roles in pain modulation, immune function, and neural signaling, but individual variation in endocannabinoid tone and metabolism—influenced by genetics, comorbidities, and concurrent medications—means that exogenous cannabinoid effects will differ substantially between patients. When counsel